Largest pharmaceuticals by earnings

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Viatris has the lowest figure of the 61 pharmaceuticals ranked by earnings, at -$3.5B, followed by Insmed (-$1.3B) and Summit Therapeutics (-$1.1B). Figures as of 18 Nov 2026, 13:16 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
61
Lowest
Viatris-$3.5B
Median
$59M
Combined market value
$5.16T
Countries
10

Market values as of .

Largest pharmaceuticals by earnings
#CompanyEarnings ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ViatrisVTRS · Health Care-$3.5B$23.4B$20.45 1.40% down 96% up United States
2InsmedINSM · Health Care-$1.3B$26.7B$121.86 0.83% down 40% down United States
3Summit TherapeuticsSMMT · Health Care-$1.1B$8.5B$10.67 9.73% down 36% down United States
4Takeda PharmaceuticalTAK · Health Care-$954.4M$69.1B$21.64 0.23% up 54% up Japan
5CytokineticsCYTK · Health Care-$785M$7.2B$51.65 2.86% down 20% down United States
6BridgeBio PharmaBBIO · Health Care-$732.9M$15B$76.80 0.72% down 17% up United States
7Ionis PharmaceuticalsIONS · Health Care-$381.4M$4.5B$26.96 3.75% down 64% down United States
8ABIVAXABVX · Health Care-$372.9M$7.2B$82.10 1.81% down 27% down France
9Jazz PharmaceuticalsJAZZ · Health Care-$356.1M$15.5B$240.71 0.39% up 37% up Ireland
10Cogent BiosciencesCOGT · Health Care-$328.9M$4.8B$27.85 1.49% up 20% down United States
11Praxis Precision MedicinesPRAX · Health Care-$303.3M$8.5B$305.06 1.68% down 61% up United States
12Roivant SciencesROIV · Health Care-$299.8M$28B$38.71 0.26% up 90% up United Kingdom
13Legend BiotechLEGN · Health Care-$296.8M$3.1B$16.11 0.75% up 42% down United States
14Madrigal PharmaceuticalsMDGL · Health Care-$288.3M$9.8B$421.99 0.46% down 24% down United States
15Ascendis PharmaASND · Health Care-$253M$17.8B$271.19 0.20% down 28% up Denmark
16Elanco Animal HealthELAN · Health Care-$232M$12.9B$25.85 2.12% down 20% up United States
17Rhythm PharmaceuticalsRYTM · Health Care-$196.5M$8.1B$116.61 8.49% up 13% up United States
18Definium TherapeuticsDFTX · Health Care-$183.8M$4B$29.38 2.59% down 169% up United States
19Axsome TherapeuticsAXSM · Health Care-$183.2M$7.2B$135.95 0.77% down 7% down United States
20Edgewise TherapeuticsEWTX · Health Care-$167.8M$4.6B$42.04 3.75% down 88% up United States
21Dianthus TherapeuticsDNTH · Health Care-$162.3M$4.9B$86.98 2.87% down 113% up United States
22Spyre TherapeuticsSYRE · Health Care-$155.2M$8.9B$93.81 5.60% down 286% up United States
23Protagonist TherapeuticsPTGX · Health Care-$130.1M$8.1B$124.67 0.13% down 46% up United States
24ErascaERAS · Health Care-$124.5M$4.9B$13.89 8.07% down 403% up United States
25Oruka TherapeuticsORKA · Health Care-$105.4M$6.5B$96.32 2.94% down 241% up United States
26Belite BioBLTE · Health Care-$77.6M$6.4B$157.72 2.98% down 31% up United States
27VeradermicsMANE · Health Care-$70M$5.3B$125.64 1.88% down 233% up United States
28Travere TherapeuticsTVTX · Health Care-$25.5M$4.9B$51.10 2.82% up 44% up United States
29Mirum PharmaceuticalsMIRM · Health Care-$23.4M$6B$91.95 0.40% up 31% up United States
30Arrowhead PharmaceuticalsARWR · Health Care-$1.6M$6.1B$42.99 2.76% down 10% up United States
31Kiniksa Pharmaceuticals InternationalKNSA · Health Care$59M$7.5B$95.11 0.93% up 126% up United Kingdom
32Amneal PharmaceuticalsAMRX · Health Care$72.1M$7.4B$21.12 0.52% down 83% up United States
33Corcept TherapeuticsCORT · Health Care$99.7M$7.7B$70.07 1.23% up 8% down United States
34Ligand PharmaceuticalsLGND · Health Care$124.5M$5.9B$293.81 2.62% down 43% up United States
35AlkermesALKS · Health Care$241.7M$7.6B$45.45 2.32% down 58% up Ireland
36BeOne MedicinesONC · Health Care$286.9M$47.2B$413.26 0.48% up 17% up Switzerland
37Alnylam PharmaceuticalsALNY · Health Care$313.7M$21B$156.50 2.02% down 66% down United States
38BioMarin PharmaceuticalBMRN · Health Care$348.9M$11.3B$58.51 0.90% up 11% up United States
39GrifolsGRFS · Health Care$446M$5.9B$8.63 1.15% down 1% up Spain
40TG TherapeuticsTGTX · Health Care$447.2M$9.5B$62.71 0.08% down 107% up United States
41Dr. Reddy's LaboratoriesRDY · Health Care$456M$12.3B$14.79 0.61% up 5% up India
42PTC TherapeuticsPTCT · Health Care$682.6M$5B$60.36 1.00% down 20% down United States
43Royalty PharmaRPRX · Health Care$770.9M$39.5B$68.68 0.23% up 78% up United States
44GenmabGMAB · Health Care$963M$32B$51.96 0.76% up 70% up Denmark
45United TherapeuticsUTHR · Health Care$1.3B$24.9B$584.10 0.64% down 23% up United States
46Teva Pharmaceutical IndustriesTEVA · Health Care$1.4B$49.7B$42.62 0.12% up 74% up Israel
47ZoetisZTS · Health Care$2.7B$33.9B$83.48 1.08% down 29% down United States
48Vertex PharmaceuticalsVRTX · Health Care$4B$135.4B$534.20 0.67% down 27% up United States
49AbbVieABBV · Health Care$4.2B$517.6B$292.82 0.59% down 26% up United States
50Regeneron PharmaceuticalsREGN · Health Care$4.5B$99.1B$957.76 0.56% up 36% up United States
51Abbott LaboratoriesABT · Health Care$6.5B$181.4B$104.71 2.55% down 17% down United States
52Bristol-Myers SquibbBMY · Health Care$7.1B$125.4B$61.35 2.51% down 34% up United States
53GSKGSK · Health Care$7.6B$98.7B$49.24 2.32% down 6% up United Kingdom
54PfizerPFE · Health Care$7.8B$162.3B$28.47 1.35% down 14% up United States
55SanofiSNY · Health Care$8.7B$114.1B$47.53 1.78% down 4% down France
56AstraZenecaAZN · Health Care$10.2B$282.7B$182.27 0.95% down 2% up United Kingdom
57NovartisNVS · Health Care$14B$300.5B$159.13 0.67% down 25% up Switzerland
58Novo NordiskNVO · Health Care$15.2B$179.4B$40.70 2.16% down 17% down Denmark
59Merck & CoMRK · Health Care$18.3B$353.4B$143.37 0.75% down 51% up United States
60Eli LillyLLY · Health Care$20.6B$1.26T$1,415.55 1.13% down 35% up United States
61Johnson & JohnsonJNJ · Health Care$26.8B$670.9B$278.70 1.36% down 38% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which pharmaceuticals have the lowest earnings?

Viatris (-$3.5B), Insmed (-$1.3B) and Summit Therapeutics (-$1.1B) have the lowest earnings of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 13:16 UTC.

How many pharmaceuticals are in this ranking?

61 are ranked by earnings.

What are these pharmaceuticals worth together?

The 61 pharmaceuticals ranked by earnings have a combined market value of $5.16T as of 18 Nov 2026, 13:16 UTC.

What does ranking by earnings measure?

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Cite this page

Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings

Underlying data: Yahoo Finance; SEC EDGAR.